CH589453A5 - - Google Patents

Info

Publication number
CH589453A5
CH589453A5 CH44774A CH44774A CH589453A5 CH 589453 A5 CH589453 A5 CH 589453A5 CH 44774 A CH44774 A CH 44774A CH 44774 A CH44774 A CH 44774A CH 589453 A5 CH589453 A5 CH 589453A5
Authority
CH
Switzerland
Application number
CH44774A
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH44774A priority Critical patent/CH589453A5/xx
Priority to NO750031A priority patent/NO143128C/en
Priority to DK1475AA priority patent/DK140003B/en
Priority to FI750014A priority patent/FI54053C/en
Priority to SE7500130A priority patent/SE427238B/en
Priority to DE2500785A priority patent/DE2500785B2/en
Priority to NL7500301.A priority patent/NL166622C/en
Priority to IE59/75A priority patent/IE40794B1/en
Priority to ES433759A priority patent/ES433759A1/en
Priority to PH16702A priority patent/PH14458A/en
Priority to DD183614A priority patent/DD116239A5/xx
Priority to YU58/75A priority patent/YU41289B/en
Priority to GB1290/75A priority patent/GB1498261A/en
Priority to PL1975177303A priority patent/PL93689B1/pl
Priority to HU75SA2736A priority patent/HU173920B/en
Priority to CA217,790A priority patent/CA1049406A/en
Priority to IL46426A priority patent/IL46426A/en
Priority to AT21475A priority patent/AT345449B/en
Priority to JP50006975A priority patent/JPS58407B2/en
Priority to BE152368A priority patent/BE824372A/en
Priority to SU752101722A priority patent/SU616997A3/en
Priority to AU77305/75A priority patent/AU500250B2/en
Priority to ZA00750259A priority patent/ZA75259B/en
Priority to CS75255A priority patent/CS191254B2/en
Priority to FR7501007A priority patent/FR2257305B1/fr
Priority to US05/687,453 priority patent/US4064232A/en
Publication of CH589453A5 publication Critical patent/CH589453A5/xx
Priority to US05/836,015 priority patent/US4140762A/en
Priority to HK563/80A priority patent/HK56380A/en
Priority to JP56012831A priority patent/JPS6035326B2/en
Priority to MY204/81A priority patent/MY8100204A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
CH44774A 1974-01-14 1974-01-14 CH589453A5 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14
NO750031A NO143128C (en) 1974-01-14 1975-01-06 PROCEDURE FOR INSULATING HEMAGGLUTIN AND NEURAMINIDASE INGREDIENTS FROM AN INFLUENCE VIRUS
DK1475AA DK140003B (en) 1974-01-14 1975-01-06 Method for isolating hemagglutinin and neuraminidase components from an influenza virus.
FI750014A FI54053C (en) 1974-01-14 1975-01-06 FOERFARANDE FOER ISOLERING AV HEMAGGLUTININ- OCH NEURAMINIDASBESTAONDSDELARNA UR ETT INFLUENSAVIRUS
SE7500130A SE427238B (en) 1974-01-14 1975-01-07 SET TO INSULATE INFLUENCEVIRUS SUBSTANCES
DE2500785A DE2500785B2 (en) 1974-01-14 1975-01-10 Process for the detachment and isolation of hemagglutinin and neuraminidase from an influenza virus
NL7500301.A NL166622C (en) 1974-01-14 1975-01-10 PROCESS FOR THE COLLECTION OF HEMAGGLUTININ AND NEURAMINIDASE FROM AN INFLUENZA VIRUS AND FOR PREPARING AN INFLUENZA VACCINE CONTAINING SO-HEMAGGLUTININ AND NEURAMINIDASE.
CA217,790A CA1049406A (en) 1974-01-14 1975-01-13 Isolation of hemagglutinin and neuraminidase from influenza virus
ES433759A ES433759A1 (en) 1974-01-14 1975-01-13 Influenza vaccines
PH16702A PH14458A (en) 1974-01-14 1975-01-13 Process for isolating the immunogenic components of influenza viruses
DD183614A DD116239A5 (en) 1974-01-14 1975-01-13
YU58/75A YU41289B (en) 1974-01-14 1975-01-13 Process for isolating hemaggutinin and heur aminidase componenets from influenza viruses
GB1290/75A GB1498261A (en) 1974-01-14 1975-01-13 Influenza vaccines
PL1975177303A PL93689B1 (en) 1974-01-14 1975-01-13
HU75SA2736A HU173920B (en) 1974-01-14 1975-01-13 Process for the selective isolation of a mixture of hemagglutinin and neuraminidase from influenza virus
IE59/75A IE40794B1 (en) 1974-01-14 1975-01-13 Influenza vaccines
IL46426A IL46426A (en) 1974-01-14 1975-01-13 Influenza vaccines and their production
AT21475A AT345449B (en) 1974-01-14 1975-01-13 METHOD FOR PRODUCING INFLUENZAVIRUS COMPONENTS
JP50006975A JPS58407B2 (en) 1974-01-14 1975-01-14 Method for separating hemagglutinin and neuraminidase components from influenza virus
BE152368A BE824372A (en) 1974-01-14 1975-01-14 INFLUENZA VACCINES AND PROCEDURE FOR THEIR PREPARATION
SU752101722A SU616997A3 (en) 1974-01-14 1975-01-14 Method of isolating hemagglutinins and neuraminidase
AU77305/75A AU500250B2 (en) 1974-01-14 1975-01-14 Influenza vaccine
ZA00750259A ZA75259B (en) 1974-01-14 1975-01-14 Improvements in or relating to organic compounds
CS75255A CS191254B2 (en) 1974-01-14 1975-01-14 Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza
FR7501007A FR2257305B1 (en) 1974-01-14 1975-01-14
US05/687,453 US4064232A (en) 1974-01-14 1976-05-18 Process for isolating the immunogenic components of influenza viruses
US05/836,015 US4140762A (en) 1974-01-14 1977-09-23 Influenza sub-unit vaccine
HK563/80A HK56380A (en) 1974-01-14 1980-10-09 Influenza vaccines
JP56012831A JPS6035326B2 (en) 1974-01-14 1981-01-29 Manufacturing method for influenza vaccine
MY204/81A MY8100204A (en) 1974-01-14 1981-12-30 Influenza vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
CH589453A5 true CH589453A5 (en) 1977-07-15

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14

Country Status (27)

Country Link
JP (2) JPS58407B2 (en)
AT (1) AT345449B (en)
AU (1) AU500250B2 (en)
BE (1) BE824372A (en)
CA (1) CA1049406A (en)
CH (1) CH589453A5 (en)
CS (1) CS191254B2 (en)
DD (1) DD116239A5 (en)
DE (1) DE2500785B2 (en)
DK (1) DK140003B (en)
ES (1) ES433759A1 (en)
FI (1) FI54053C (en)
FR (1) FR2257305B1 (en)
GB (1) GB1498261A (en)
HK (1) HK56380A (en)
HU (1) HU173920B (en)
IE (1) IE40794B1 (en)
IL (1) IL46426A (en)
MY (1) MY8100204A (en)
NL (1) NL166622C (en)
NO (1) NO143128C (en)
PH (1) PH14458A (en)
PL (1) PL93689B1 (en)
SE (1) SE427238B (en)
SU (1) SU616997A3 (en)
YU (1) YU41289B (en)
ZA (1) ZA75259B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (en) * 1977-07-13 1979-02-01 Sandoz Ag SUBUNIT VACCINE
JPH0688911B2 (en) * 1985-06-06 1994-11-09 国立予防衛生研究所長 Influenza vaccine and method for producing the same
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
JP5602366B2 (en) * 2005-11-01 2014-10-08 ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー Viral vaccine derived from cells containing low levels of residual cellular DNA treated with β-propiolactone
JP5535910B2 (en) * 2007-08-28 2014-07-02 バクスター・インターナショナル・インコーポレイテッド How to produce a viral vaccine
WO2015071177A1 (en) 2013-11-15 2015-05-21 Novartis Ag Removal of residual cell culture impurities

Also Published As

Publication number Publication date
ES433759A1 (en) 1977-02-16
AU500250B2 (en) 1979-05-17
MY8100204A (en) 1981-12-31
FI54053B (en) 1978-06-30
AT345449B (en) 1978-09-11
IE40794L (en) 1975-07-14
JPS58407B2 (en) 1983-01-06
NL166622B (en) 1981-04-15
SE427238B (en) 1983-03-21
DD116239A5 (en) 1975-11-12
GB1498261A (en) 1978-01-18
YU41289B (en) 1987-02-28
PH14458A (en) 1981-07-29
HK56380A (en) 1980-10-16
SU616997A3 (en) 1978-07-25
IL46426A (en) 1978-01-31
JPS50100224A (en) 1975-08-08
NL166622C (en) 1981-09-15
PL93689B1 (en) 1977-06-30
FR2257305A1 (en) 1975-08-08
NO143128B (en) 1980-09-15
NO143128C (en) 1980-12-29
ZA75259B (en) 1976-08-25
JPS6035326B2 (en) 1985-08-14
SE7500130L (en) 1975-07-15
DK140003C (en) 1979-10-29
DK1475A (en) 1975-09-01
DE2500785A1 (en) 1975-07-31
CS191254B2 (en) 1979-06-29
AU7730575A (en) 1976-07-15
BE824372A (en) 1975-07-14
IE40794B1 (en) 1979-08-15
DE2500785B2 (en) 1980-01-03
NO750031L (en) 1975-08-11
ATA21475A (en) 1978-01-15
DE2500785C3 (en) 1980-09-11
DK140003B (en) 1979-06-05
IL46426A0 (en) 1975-04-25
FR2257305B1 (en) 1982-03-19
HU173920B (en) 1979-09-28
CA1049406A (en) 1979-02-27
YU5875A (en) 1984-04-30
NL7500301A (en) 1975-07-16
FI54053C (en) 1978-10-10
FI750014A (en) 1975-07-15
JPS56127319A (en) 1981-10-06

Similar Documents

Publication Publication Date Title
BR7501650A (en)
FR2257305B1 (en)
JPS50143113A (en)
FR2286286B1 (en)
AU479230B2 (en)
AU7474774A (en)
AU1893276A (en)
JPS50150598U (en)
CH199074A4 (en)
BG21557A1 (en)
CH1131875A4 (en)
CH1132074A4 (en)
BG21674A1 (en)
BG22325A1 (en)
BG22209A1 (en)
CH1189874A4 (en)
BG19728A1 (en)
CH131574A4 (en)
CH567803A5 (en)
BG19776A1 (en)
BG20244A1 (en)
BG20418A1 (en)
CH564866A5 (en)
BG21664A1 (en)
BG26365A3 (en)

Legal Events

Date Code Title Description
PUE Assignment

Owner name: DUPHAR INTERNATIONAL RESEARCH B.V.

PL Patent ceased